To explore the role of FGF20 in pathological cardiac hypertrophy, we first examined the level of FGF20 in the heart from mice subjected to transverse aortic constriction (TAC) surgery for 6 weeks or sham-operated mice. This evidence concerns the gene FGF20 and cardiac hypertrophy.